The Eyes of Inam Butt: A Two-Month Ban and the Crack Inside Pakistan Wrestling's Therapeutic Use Exemption System

Hook

Inam Butt stood on the silver-medal podium at the Asian Beach Games last April. Television audiences saw a Pakistani wrestler with a solemn posture, hands clasped around the medal against his chest, eyes fixed on the flag. I saw something else. Butt's eyes were faintly red and slightly swollen — a detail only visible to those who once sat close enough to the mat. Those eyes told a different story from the medal on his chest. People saw Butt collect silver. I saw his eyes crying for help.

Three months later, the International Testing Agency (ITA) opened an anti-doping file against Butt. The sample taken at the Games showed traces of an ophthalmic medication. No anabolic steroids. No growth hormone. No stimulants. A drug used to treat an eye condition — and that was the entire substance of the violation.

The story can be told two ways. The first is a story of relief: an athlete with an eye disease, using physician-prescribed medication, failing to file the paperwork in time, and now facing perhaps only a two-month ban — far less than the four-year maximum. The second is a story about systems: a minor administrative lapse can strip an international medal from an athlete, while the Therapeutic Use Exemption (TUE) framework itself still holds gaps nobody has closed.

I follow the second path.

Context — Background and Subject

Inam Butt, past his mid-thirties, is not an unfamiliar name in international wrestling. He once held a beach-wrestling world title — a young UWW discipline staged on sand rather than mats. Beach wrestling runs on shorter rules than freestyle, with faster-paced exchanges, and demands balance on an unstable surface — something many freestyle wrestlers struggle with on first contact.

In Pakistan, wrestling holds a special cultural position. The sport is tied to akhara — traditional outdoor training pits in Punjab where generations of wrestlers still practise in classical methods, mixing morning conditioning with afternoon technique. Butt is regarded as one of the finest products of that lineage. Beach wrestling, however, is a different ecosystem: limited infrastructure, low prize pools, and a much smaller field of competing nations than Olympic freestyle or Greco-Roman. A world title in this discipline still carries genuine athletic weight, but it sits inside a narrower competitive pyramid.

Butt's professional structure matters more than any title. He is simultaneously Pakistan's national squad coach, secretary of the Pakistan Wrestling Federation (PWF), and chairman of the Pakistan Olympic Association (POA) athletes commission. Three roles across one system — athlete, coach, administrator — is not rare in small federations, where the talent pool is too thin to separate responsibilities cleanly.

Inside a doping file, this structure becomes a problem. When a person is the subject of an investigation, a voice on the athletes commission, and the federation's secretary, the procedural integrity is called into question — not because the individual is at fault, but because the structure creates conflict of interest. That is why Butt decided to step down voluntarily from his administrative posts while the file was processed, citing the sport's interests and the need for impartiality.

On the medical side: reports indicate Butt suffers from an eye condition requiring long-term medication. The drug he used belongs to a WADA-controlled class. Under IOC and WADA rules, athletes have the right to apply for a Therapeutic Use Exemption (TUE) before using a banned substance. But to get one, an athlete must build a medical dossier, file it with the competent body, and receive approval before competition. That process demands time and administrative literacy — two things many athletes at small federations do not have.

The Asian Beach Games in April were Butt's main stage of the year. He won silver — a significant result for an athlete past peak and transitioning toward coaching. But the sample taken at those Games is the origin of the doping file. That coincidence — peak achievement and a rule infraction at the same event — is common in therapeutic-use doping cases.

Core — Central Analysis

The Inam Butt case belongs to the global anti-doping governance layer, not to training methodology or tactical review. That means it must be read in the language of law, administrative procedure, and the principle of responsibility.

Anatomy of a TUE file

A Therapeutic Use Exemption allows an athlete to use a banned substance if it is necessary for treating a diagnosed condition and not for performance enhancement. Four conditions must be met: a clear medical diagnosis, no effective alternative, use at therapeutic dose only, and no performance-enhancement purpose. If all four are met, the TUE is granted. In Butt's case, the ITA confirmed it had authorised him to use the medication for a one-year period.

Here the reporting contains a contradiction. The same source states Butt failed to secure the TUE in time, then elsewhere states the ITA granted him one year of authorised use. The two can only reconcile if the TUE covered a different window, or was granted retroactively after the fact. Either way, it shows the TUE system operates in ways athletes themselves sometimes do not fully understand.

From my own experience tracking doping files across Southeast Asia, most therapeutic-use cases share one pattern: the violation is not in the substance, but in the paperwork. Athletes usually know what they are taking. They do not know that prior approval is required. Small federations — PWF included — rarely employ a dedicated TUE officer. Athletes must research the prohibited list, file the dossier, and track renewal deadlines themselves.

That is the first point of system fracture. I believe in quietly archived numbers more than loud promises — and here the number that matters most is the number of preparation days, not the number of months in the sanction.

Strict liability

The second point concerns strict liability under the WADA World Anti-Doping Code. Under that principle, an athlete is responsible for every substance in their body, regardless of cause. If a sample is positive, the athlete is deemed in violation — unless they can prove no fault or no significant fault. In Butt's case, the ITA accepted the medication was for eye treatment, not enhancement. The violation lies in procedure, not purpose.

The reported sanction is around two months, backdated to April. That matches the "no significant fault or negligence" model in the WADA Code. The standard ban for doping violations is four years. Two years applies to ordinary negligence. Less than two years applies to minor or no significant fault. Two months sits at the very bottom of that range — a signal the ITA judged severity low.

But a suspended ban does not erase the file. Under strict liability, medal forfeiture is automatic and independent of the degree of fault. The silver medal Butt won at the April Asian Beach Games will be stripped. That part is irreversible.

What is academically notable is that the reporting frames the case in the language of "relief" and a "light sanction". Meanwhile, a stripped international medal is a concrete loss — not offset by a shortened ban. The competition sanction is a negotiable variable. The lost medal is a fixed one.

ITA's role in governance

The third point, less explored by media, concerns the ITA's role. Previously, doping files were handled by national federations or national Olympic committees. The decade-long trend has been to delegate authority to independent international bodies such as the ITA, reducing political pressure and conflict of interest. For an athlete who is simultaneously an investigation subject and a federation official, ITA handling protects both Butt and the PWF.

In many small federations, doping authority sits with people who have personal relationships with the athlete. Results are often suspected of partiality. The ITA — as an IOC-mandated independent testing body — is designed to avoid that. In Butt's case, ITA handling is not just technical, but political: a federation like the PWF can hardly process the file of its own secretary without suspicion of favouritism.

Where medicine meets governance

The fourth point concerns the medical-governance interface. Butt's eye condition is not a competition-performance issue — it is a health issue. But within anti-doping governance, an athlete's health is protected only if the administrative file is prepared correctly. An athlete's body may be undergoing treatment, but if the paperwork is not in order, the system still processes it as if it were cheating. That is a feature many athletes only learn once they are inside it.

Across 23 years observing martial systems in Asia, I have seen the same structure in many small federations. In Thailand, the Philippines, Indonesia — where I have tracked doping files — the problem is never the banned substance. It is that athletes lack procedural guidance. They are asked to comply with a complex body of rules while the system provides no matching resources.

The Butt case exposes an uncomfortable truth: in today's anti-doping framework, administrative responsibility is placed on the athlete, while administrative resources are not allocated correspondingly. This asymmetry is a structural feature, not an individual flaw.

Reading eye pathology in combat sports

One more medical angle is required. In combat sports — wrestling, boxing, judo — eye pathology directly affects the ability to compete. Eye injuries, uveitis, glaucoma, or retinal conditions can all impair vision and reflex. For a wrestler, the ability to read an opponent and maintain balance depends heavily on sight. Treating an eye condition is not optional — it is a condition for competing safely.

Many ophthalmic medications — such as topical corticosteroids or anti-inflammatories — sit on the WADA prohibited list because they can be abused for short-term pain masking and performance gains. Athletes with chronic eye disease must balance treatment against compliance. That is a dual burden athletes at large federations have medical teams to manage, while athletes at small federations shoulder alone. Butt's file taught me that medical data is never innocent — it is simply waiting for a reader.

Contrarian — Counter-intuitive Angle

The reporting on Butt is framed as "relief": short ban, medal unsalvageable, career possibly continuing. That frame favours the athlete. But from a systems view, it overlooks a larger problem.

The first issue is reliance on unnamed sources. The most important details — ITA accepting the medical explanation, a two-month expected ban, the one-year authorisation — all come from unnamed sources. Until the ITA publishes its formal decision, these are indirect claims. In anti-doping journalism, the gap between indirect reporting and formal ruling is wide.

The second issue is the "just paperwork" frame. Describing Butt's infraction as a minor administrative lapse may be technically accurate, but it glosses over the practical consequence: an international medal forfeited. In Olympic sport, the medal is the final unit of achievement. An athlete can accept a competition ban, but cannot recover a medal already stripped.

The third issue concerns role structure. Butt being athlete, national coach, federation secretary, and athletes-commission chairman simultaneously is the sign of a thin governance system. In large federations, those four roles sit with four different people — usually four people with different interests, overseeing each other. In small federations, they sit with one person because no one else is available.

The fault is not Butt's. It is a structural feature of national sport in resource-constrained countries. But it creates a problem: when one person holds many roles, processing that person's doping file becomes a political problem, not merely a legal one. Butt's voluntary step-down was the correct handling — but it also reveals that the system has no automatic mechanism to separate roles when conflict of interest arises.

The fourth issue is misunderstanding the concept of "light". A two-month ban is described as light versus the maximum. But in this specific case — an athlete in late career, already transitioning into coaching — two months of ineligibility may mean never competing again. The time horizon of an athlete's career is not the time horizon of a legal system. What counts as "light" in legal language can be "the end" in career language.

Finally, the "relief" frame overlooks whether the TUE system can protect athletes with chronic illness. If an athlete needs lifelong eye medication, they must renew the TUE every year, monitor dosage, and coordinate with physicians to ensure the medication does not breach the prohibited list. That is a continuing administrative burden, not a one-off event. The Butt case shows that burden can become a legal risk when mismanaged.

Takeaway — A Forward-Looking Reflection

Inam Butt's story does not end when the ITA publishes its decision. It opens a larger question about how the international sports system handles athletes with chronic illness.

In large federations, athletes have their own medical staff, TUE counsel, and an administrative unit tracking paperwork deadlines. In small federations, athletes do it all themselves. The gap between the two groups is not compliance capacity — it is resource allocation. Same rule, two enforcement standards.

If the ITA publishes its decision as expected — two-month ban, medal stripped — Butt will become a case study in how the system handles administrative lapses. This case is about the gap between rule and capacity to comply, more than about cheating.

With Butt's current roles — national coach, federation official — the experience can become a lesson for the next generation of Pakistani athletes. If he can convey the importance of preparing a TUE dossier correctly, the price of two months of ineligibility may yield long-term value.

What remains to be seen is whether the PWF and the POA will restructure governance to separate athlete, coach, and official roles. If not, the next case will repeat the same script — not because the individual failed, but because the system never gave them the right opportunity.

Inam Butt's eyes still need treating. The body never negotiates — it only signs the verdict quietly in advance. The question facing the sports system now is whether it can learn to protect those who must live with chronic illness — before a late piece of paper turns them into investigation subjects.